Brunswick director granted 527 common shares
MCCLANATHAN JOSEPH W reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MCCLANATHAN JOSEPH W reported acquisition or exercise transactions in this Form 4 filing.
BRUNSWICK CORP director Joseph W. McClanathan received a stock award of 527 shares of common stock. The shares were granted at a reference price of $79.45 per share and are held directly.
After this grant, his direct holdings total 27,562 Brunswick shares, indicating this was a relatively small, routine compensation-related award.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 527 | $79.45 | $42K |
Footnotes (1)
- F1. Beneficial holdings include 137 shares acquired pursuant to dividend reinvestment through March 2026.
Key Figures
Key Terms
Grant, award, or other acquisition financial
beneficial holdings financial
dividend reinvestment financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Brunswick (BC) director Joseph W. McClanathan report on this Form 4?
Was the Brunswick (BC) Form 4 transaction a purchase or a grant?
At what price was Joseph W. McClanathan’s Brunswick (BC) stock award valued?
What does the dividend reinvestment footnote mean for Brunswick (BC) director holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.